GHIG regards its work to be of the highest quality and submits to peer-review as often as possible. We have been honored to co-author with distinguished institutions and organizations in…
Read More
GHIG was asked to serve as an advisor collaborating with Cambridge Economic Policy Associates (CEPA) to evaluate the return on investment of early infant diagnosis (EID) and viral load (VL)…
Read More
Recent advances with Prevent of Mother-to-Child Transmission (PMTCT) and Early Infant Diagnosis (EID) programs due to Option B+ and at birth testing have created challenges with specificity of EID testing…
Read More
In 2015, GHIG provided technical input to support the World Health Organization (WHO) HIV/AIDS Treatment and Care Unit normative documents for the ARV Guidelines. These documents informed the 2015 update…
Read More
The Global Health Impact Group (GHIG) provided technical assistance and direction to the 3-year project funded by Unitaid to the London School of Hygiene and Tropical Medicine (LSHTM) to provide…
Read More
